Last reviewed · How we verify
Furagin (furazidin)
Furagin (generic name: furazidin) is a drug. It is currently in unknown development for Urinary tract infectious disease.
Furagin works by inhibiting bacterial growth and replication, specifically targeting the bacterial enzyme responsible for DNA synthesis.
Furagin (furazidin) is a small molecule modality developed for the treatment of urinary tract infectious diseases. Although its exact target and drug class are unknown, it has been approved for use in treating urinary tract infections. The commercial status of Furagin is unclear, with no information available on its patent status or generic manufacturers. Further research is needed to fully understand its pharmacokinetic properties and potential safety considerations. As a result, its use should be approached with caution and under the guidance of a qualified healthcare professional.
At a glance
| Generic name | furazidin |
|---|---|
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Mechanism of action
Think of it like a brake on a car - Furagin puts the brakes on bacterial growth by stopping the enzyme that helps bacteria make copies of themselves. This prevents the infection from getting worse and allows the body's immune system to fight off the infection. By stopping bacterial growth, Furagin helps to clear up the infection and prevent further complications.
Approved indications
- Urinary tract infectious disease
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Furagin CI brief — competitive landscape report
- Furagin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Furagin
What is Furagin?
How does Furagin work?
What is Furagin used for?
What is the generic name of Furagin?
What development phase is Furagin in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Indication: Drugs for Urinary tract infectious disease
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing